The Itch: Allergies, Asthma, Eczema & Immunology

Starting biologic therapy can be life-changing, but navigating the process isn’t always easy.

Dr. William Anderson joins Dr. Gupta and Kortney to break down the essential steps for starting biologic therapy, covering everything you need to know before beginning treatment. Biologics are at the forefront of managing chronic allergic diseases like asthma and eczema, offering targeted, personalized care that can improve patients’ quality of life. However, accessing these medications often requires navigating a maze of insurance approvals, prior authorizations, and specialty pharmacies.

We dive deep into the challenges patients face when starting biologics—understanding how to get coverage, managing co-pays, and coordinating with specialty pharmacies, all while handling the logistics of administering the medication. As someone who has just started a biologic herself, Kortney shares her own experience and reflects on how this episode provides the exact information she wished she’d had a few months ago.

• Getting informed before starting biologic therapy: Dr. Anderson explains why reviewing your medication’s patient website is a great first step. These resources often include videos and important details about the treatment.

About our biologics expert, Dr. William Anderson

Dr. William Anderson, is a board-certified pediatric allergist and immunologist at Children’s Hospital Colorado. With a focus on treating children with complex allergic conditions such as asthma, eczema, and food allergies, Dr. Anderson is known for his patient-centered approach. He has extensive experience in biologic therapies and is dedicated to improving the quality of life for patients through personalized care. Dr. Anderson also actively participates in clinical research, staying at the forefront of advances in allergy and immunology treatments.

More resources about biologic therapies and the conditions they treat: 

• A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology

This podcast is made in partnership with The Allergy & Asthma Network. Thanks to Sanofi-Regeneron for sponsoring today’s episode. While they support the show, all opinions are our own, and sponsorship doesn’t influence our content or editorial decisions. Any mention of brands is for informational purposes and not an endorsement.

Curious about what’s fact and what’s fiction when it comes to biologic medications?

We’re uncovering the truth behind the most pervasive myths about biologic medications with guest Dr. Cedric “Jamie” Rutland. Biologics are revolutionizing the treatment of allergic diseases like asthma and eczema, but misconceptions about their effectiveness, safety, and usage still persist. Dr. Rutland sets the record straight, debunking myths that may be clouding your understanding and decision-making process.

From whether biologics are a cure to concerns about long-term safety and side effects, this episode tackles the most common myths head-on. Dr. Rutland breaks down what biologic therapy truly offers, helping you make informed decisions about your treatment options.

• Are biologics a cure? Dr. Rutland explains that biologics help manage symptoms, but they are not a complete cure.

• Administration of biologics: We address the myth that biologics must be administered only in hospitals, explaining how patients can receive them at home or in clinics.

More resources about biologic therapy and the conditions they treat: 

• https://biologicmeds.org/

What are biologic medications, and how can they help people with allergic diseases?

We discuss biologic medications with Dr. Berger, a leading expert in biologic therapy for allergic diseases. Since the first biologic was introduced in 2003, these treatments have advanced significantly. By targeting the root causes of inflammation, biologics offer a more precise, personalized approach to treating conditions like asthma and eczema. Unlike traditional medications, biologics are a breakthrough, opening the door to tailored care that improves patients' long-term symptom control and quality of life.

Dr. Berger explains biologic medications, how they work at a molecular level, and how they impact the immune system. As Kortney recently started biologic therapy, we also get a firsthand account of patients' decision-making process and concerns when considering biologic treatments. These innovative therapies not only control symptoms but can transform the daily lives of people living with chronic allergic diseases, providing hope for better, long-term outcomes.

• What is a biologic medication? Dr. Berger explains how biologic medications differ from traditional treatments by focusing on precision-based medicine, offering a revolutionary way to target specific aspects of the immune system.

Dr. William E. Berger is a past Clinical Professor in the Department of Pediatrics at the University of California-Irvine and served as Medical Director of Southern California Research in Mission Viejo. He is a board-certified allergist and immunologist with a distinguished career, including roles as President of the American College of Allergy, Asthma & Immunology and as Medical Staff Allergist for the U.S. Olympic Swim Team. Dr. Berger has published over 200 peer-reviewed articles and authored books like Asthma for Dummies, focusing on allergy and asthma treatments. He is widely recognized as an expert in his field, frequently appearing on major media outlets like CNN and Good Morning America.

More resources about biologic therapy: 

• https://biologicmeds.org/

This podcast is made in partnership with The Allergy & Asthma Network. Thanks to Sanofi-Regeneron for sponsoring today’s episode. While they support the show, all opinions are our own, and sponsorship doesn’t influence our content or editorial decisions. Any mention of brands is for informational purposes and not an endorsement.

There’s never been a better time to be a CSU patient, with cutting-edge therapies and revolutionary treatments just around the corner. As research accelerates, new and promising options that could significantly improve the quality of life for those living with Chronic Spontaneous Urticaria are coming to market.

In this episode, Dr. Matthew Zirwas joins us to discuss the latest advancements in treating CSU, offering invaluable insights into both current and emerging treatment options. With his extensive experience and patient-centred approach, Dr. Zirwas breaks down the complexities of CSU and highlights how these new therapies can make a real difference.

This podcast was made in partnership with Allergy & Asthma Network. We thank Novartis for sponsoring this podcast.

• How Dr. Zirwas explains CSU to his patients: Discover the patient-friendly explanations that help demystify CSU and empower patients to learn more about their disease.

• Dupixent (dupilumab): A biologic administered via injection that targets key pathways in the inflammatory response.

Dr. Matthew Zirwas, MD, is a board-certified dermatologist and a nationally recognized expert in allergy patch testing, psoriasis, and eczema. He founded the Bexley Dermatology Research Clinic, offering patients access to the latest treatment options before they are widely available. Dr. Zirwas also serves as a dermatologic advisor for several companies, including ALL Laundry Detergent and Cerave, and contributes to Women’s Health Magazine. Learn more about Dr. Zirwas.

More resources about chronic spontaneous urticaria: 

• Chronic Urticaria Management, Resources & Glossary of Terms: https://allergyasthmanetwork.org/health-a-z/chronic-urticaria/management-and-resources/

Disclaimer: This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

Did you know that the month of September sees a drastic rise in asthma attacks and hospitalizations?

Dr. G and Kortney delve into the challenges that asthmatics face during the fall season, also known as "peak week." Despite what the name suggests, asthma cases start to rise in the second week of September and continue into early October before returning to normal levels.

We begin by defining asthma and then explore why asthma attacks are more prevalent in September. We discuss the role of germs and viruses, indoor and outdoor allergens, and cold weather in exacerbating asthma symptoms. Dr. G also shares tips on how to lessen your exposure to these triggers. Additionally, we cover the importance of having an asthma action plan and the significance of well-controlled asthma.

Dr. G also discusses the financial aspects of asthma management and offers advice on how to discuss this with your doctor.

>>>> Listener survey: https://forms.gle/6Pb2PGq6nuVReasZ6

• Why September is Peak Asthma Season: Explore why asthma attacks increase in the fall and what you can do to prepare.

More resources about asthma peak week: 

• Asthma and Allergy Forecast: pollen and allergen count https://allergyasthmanetwork.org/weather/

We want to thank AstraZeneca for sponsoring this episode.

Disclaimer: This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

This episode is a quick-fire round covering the misunderstood aspects of chronic spontaneous urticaria (CSU), a condition that perplexes many due to its spontaneous nature. With over 1.7 million people affected, it's more common than you might think and deserves a closer look. Despite its prevalence, many misconceptions persist about what causes CSU, its symptoms, and how it can be treated.

Kortney and Dr. Gupta tackle the myths and misconceptions around CSU. Unpacking its impacts on quality of life and the challenges those living with the condition face. They explore the realities of living with CSU, from the pervasive itch to the emotional toll it can take. Whether you're a patient, caregiver, or healthcare professional, this episode offers valuable insights into the realities of managing CSU.

This podcast was made in partnership with Allergy & Asthma Network. We thank Novartis for sponsoring this podcast.

• CSU is caused by allergies.

More resources about chronic spontaneous urticaria: 

• Chronic Urticaria Management, Resources & Glossary of Terms: https://allergyasthmanetwork.org/health-a-z/chronic-urticaria/management-and-resources/

Disclaimer: This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

Imagine being so itchy that you’d consider cutting off your skin just for relief. That’s what it can be like living with chronic spontaneous urticaria.

We sit down with Heather, a patient living with chronic spontaneous urticaria, as she candidly shares her experiences from the initial diagnosis to navigating the complex landscape of treatments and mental health support. Her story sheds light on the day-to-day struggles and triumphs of managing CSU, offering hope and practical advice for those in similar situations.

Dr. G unpacks Heather's diagnosis and treatment journey, including antihistamines and Omalizumab. Dr. G also highlights the importance of managing mental health. Kortney shares her experience of itch and, with Heather, discusses the impact of chronic itching on quality of life and how to explain this to friends and family.

• Heather's Journey with CSU: Heather shares her initial diagnosis and the rollercoaster of emotions and challenges that followed.

More resources about chronic spontaneous urticaria: 

• Chronic Urticaria Management, Resources & Glossary of Terms: https://allergyasthmanetwork.org/health-a-z/chronic-urticaria/management-and-resources/

Disclaimer: This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

Yes, there are more options than antihistamines to treat chronic spontaneous urticaria. We dive into them! 

Dr. Sheila Gogate joins us to discuss the chronic spontaneous urticaria (CSU) treatments currently available for patients. Dr. Shaila Gogate outlines the treatment journey for CSU with an emphasis on shared decision-making.  

This episode emphasizes the importance of following treatment guidelines and adjusting medications as needed. We discuss the available treatments for urticaria, including antihistamines, omalizumab (Xolair for hives), and Cyclosporine. The episode also explores the journey of managing CSU symptoms through both medical and non-medical approaches.

• Treatment Path and Guidelines: Overview of doctors' steps to treat CSU. The importance of shared decision-making in the treatment plan. 

Dr. Shaila Gogate, board-certified by the American Board of Allergy & Immunology, has been with Colorado Allergy & Asthma Centers since 2014. She completed her medical education at Chicago Medical School, her residency at Washington University, and her fellowship at National Jewish Health in Denver. Dr. Gogate has served as an Assistant Professor at the University of Colorado, has extensive clinical research experience, and emphasizes strong patient-provider communication to develop effective treatment plans.

More resources about chronic spontaneous urticaria: 

• Chronic Urticaria Management, Resources & Glossary of Terms: https://allergyasthmanetwork.org/health-a-z/chronic-urticaria/management-and-resources/

More information about XOlair: https://www.xolair.com/chronic-spontaneous-urticaria.html

How is the black community impacted by food allergies?

Dr. Carla Davis joins Dr. G and Kortney to discuss the impact of social determinants of health on food allergy outcomes within the Black community. Dr. Davis highlights historical factors like redlining and insurance disparities that exacerbate health disparities, resulting in higher prevalence rates of food allergies and multiple allergies among Black patients. These disparities often lead to increased emergency room visits and barriers to accessing allergen-free foods, compounded by socioeconomic challenges and food insecurity.

Dr. Davis also underscores how cultural differences significantly influence the management of food allergies within families, particularly during gatherings, and emphasizes the crucial role of media representation in raising awareness and promoting acceptance.

We discuss the critical need for increased Black representation in research trials, recognizing the challenges posed by longstanding mistrust in the medical community among Black patients.

Key Points Covered in This Episode:

• Health Disparities: Social factors significantly impact food allergy outcomes in the Black community.

Helpful Resources

• Health Disparities in Allergy, Asthma and Immunologic Diseases (New Webinar July 16, 2024): https://allergyasthmanetwork.org/webinars-updates/health-disparities-diseases/

Food Equality Initiative - Food Allergy Friendly Food Bank Resource: https://www.foodequalityinitiative.org/

How do you know if your hives are chronic spontaneous urticaria? 

Join Kortney and Dr. Payel Gupta in the second episode of this chronic spontaneous urticaria (CSU) series as they delve into the diagnostic journey of CSU. 

Have you wondered if the path to a chronic spontaneous urticaria diagnosis is long? CSU can feel like a very complex disease to diagnose due to the lack of identifiable triggers, but this episode breaks down the steps healthcare professionals take to diagnose CSU. 

Dr. G clarifies how allergists' and dermatologists' roles differ in diagnosing CSU. The episode emphasizes the importance of a detailed medical history and the tests involved in ruling out other conditions. It also describes the journey of determining CSU from other skin and allergic reactions through meticulous evaluation and specific testing methods.

• Introduction to CSU Diagnosis: CSU has no identifiable triggers, making diagnosis a process of elimination.

More resources about chronic spontaneous urticaria: 

• Chronic Urticaria Management, Resources & Glossary of Terms: https://allergyasthmanetwork.org/health-a-z/chronic-urticaria/management-and-resources/

This episode is produced in partnership with Allergy & Asthma Network. We want to thank Novartis for sponsoring this episode.

Disclaimer: This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.